1. Home
  2. INUV vs PLUR Comparison

INUV vs PLUR Comparison

Compare INUV & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inuvo Inc.

INUV

Inuvo Inc.

HOLD

Current Price

$1.18

Market Cap

24.2M

ML Signal

HOLD

Logo Pluri Inc.

PLUR

Pluri Inc.

HOLD

Current Price

$1.67

Market Cap

25.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INUV
PLUR
Founded
N/A
2001
Country
United States
Israel
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.2M
25.5M
IPO Year
1996
2001

Fundamental Metrics

Financial Performance
Metric
INUV
PLUR
Price
$1.18
$1.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$11.00
$12.00
AVG Volume (30 Days)
148.0K
31.1K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
50.00
10.78
EPS
0.13
N/A
Revenue
$86,209,305.00
$1,336,000.00
Revenue This Year
N/A
$97.38
Revenue Next Year
$12.89
$293.97
P/E Ratio
$8.38
N/A
Revenue Growth
2.88
309.82
52 Week Low
$1.00
$1.78
52 Week High
$6.27
$5.68

Technical Indicators

Market Signals
Indicator
INUV
PLUR
Relative Strength Index (RSI) 41.25 27.38
Support Level $1.00 N/A
Resistance Level $2.01 $2.53
Average True Range (ATR) 0.11 0.13
MACD 0.00 -0.01
Stochastic Oscillator 47.44 15.00

Price Performance

Historical Comparison
INUV
PLUR

About INUV Inuvo Inc.

Inuvo Inc is an advertising technology and services company that has developed and commercialized large language generative artificial intelligence (AI) for modeling media audiences. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: